Skip to main content
. 2021 May 6;16(6):1614–1628. doi: 10.1016/j.stemcr.2021.04.002

Figure 3.

Figure 3

Higher expression of CD150 identifies resilient LT-HSCs

(A) Flow cytometric index-sort data were used to determine the CD150 expression level of LT-HSCs at the time of isolation. Cells that did not survive at day 1 and day 7 were compared with those that survived out to day 7, with the latter population of cells correlating with higher CD150 expression. A boxplot shows the median with interquartile range. Vertical lines represent outermost quartiles. Black dots, if present, are extreme outliers. Unpaired t test: p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.

(B) Prospectively sorted CD150high LT-HSCs show 4.2-fold higher survival than CD150mid LT-HSCs (n = 480, 5 independent experiments). Paired two-tailed t test.

(C) Hibernating HSCs in serum-free and serum-supplemented conditions were transplanted, and their CD150 levels retrospectively assessed. Cells able to repopulate a recipient (black) did not differ in initial CD150 expression levels compared with cells unable to repopulate (gray).

(D) HSCs with high or low expression of CD150 were determined using index-sorting data from freshly isolated HSCs that were cultured for 7 days in serum-free medium supplemented with 20 ng/mL IL-11 and 300 ng/mL SCF. Three biological replicates were analyzed, and in each case the top third and bottom third of CD150 expressers were analyzed as CD150high and CD150low, respectively. Daily cell counts were performed to assess cell division kinetics. Entry into cell cycle and the second division were not significantly altered between CD150high and CD150low LT-HSCs.

(E) Using the same experimental data from Figure 3D, colony sizes from single LT-HSCs were measured on day 10 and clone sizes from single LT-HSCs with high expression of CD150 were significantly reduced compared with those with low CD150 expression (bars show mean with SD. Sidak's multiple comparison test: ∗∗p < 0.01).